← AVANOS MEDICAL, INC. AVNS
Market Price
$24.99
Market Cap
$1.17B
P/E Ratio
N/A
Revenue (FY 2025)
↑1.9% YoY
$701.20M
3-Yr CAGR: -5.1%
Net Income
↑81.4% YoY
-$72.90M
Net Margin: -10.4%
Free Cash Flow
↓-48.0% YoY
$43.10M
FCF Yield: 3.68%
EPS (Diluted)
↑81.6% YoY
$-1.57
Basic: $-1.57
Return on Equity
Efficiency
-9.4%
ROA: -528.3%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (AVNS)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $1,592.3M | — | $557.9M | $39.8M | — | $0.85 | — | $188.8M | $159.7M | — |
| FY 2017 | $611.6M | -61.6% | $336.9M | $79.3M | +99.2% | $1.69 | +98.8% | $144.2M | $101.0M | -36.8% |
| FY 2018 | $652.3M | +6.7% | $390.9M | $57.5M | -27.5% | $1.22 | -27.8% | $-145.6M | $-194.7M | -292.8% |
| FY 2019 | $697.6M | +6.9% | $402.2M | $-45.9M | -179.8% | $-0.96 | -178.7% | $-74.5M | $-125.1M | +35.7% |
| FY 2020 | $714.8M | +2.5% | $373.3M | $-27.2M | +40.7% | $-0.57 | +40.6% | $-2.5M | $-22.7M | +81.9% |
| FY 2021 | $744.6M | +4.2% | $364.3M | $5.2M | +119.1% | $0.11 | +119.3% | $87.3M | $66.3M | +392.1% |
| FY 2022 | $820.0M | +10.1% | $450.0M | $50.5M | +871.2% | $1.07 | +872.7% | $90.9M | $71.6M | +8.0% |
| FY 2023 | $673.3M | -17.9% | $379.7M | $-61.8M | -222.4% | $-1.32 | -223.4% | $32.4M | $14.6M | -79.6% |
| FY 2024 | $687.8M | +2.2% | $381.3M | $-392.1M | -534.5% | $-8.53 | -546.2% | $100.7M | $82.9M | +467.8% |
| FY 2025 | $701.2M | +1.9% | $353.9M | $-72.9M | +81.4% | $-1.57 | +81.6% | $74.7M | $43.1M | -48.0% |
Valuation
Market Price
$24.99
Market Cap
$1.17B
Enterprise Value
$1.18B
P/E Ratio
N/A
P/B Ratio
1.50
FCF Yield
3.68%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
50.47%
Operating Margin
-8.78%
Net Margin
-10.40%
Return on Equity (ROE)
-9.37%
Return on Assets (ROA)
-528.26%
Asset Turnover
50.81x
Revenue 3-Yr CAGR
-5.08%
Financial Health & Liquidity
Current Ratio
0.15
Cash Ratio
0.98
Debt / Equity
0.129
Debt / Assets
7.283
Cash & Equivalents
$89.80M
Total Debt
$100.50M
Book Value / Share
$16.62
Cash Flow Efficiency
Operating Cash Flow
$74.70M
Capital Expenditures (CapEx)
$31.60M
Free Cash Flow
$43.10M
OCF / Revenue
10.65%
FCF / Revenue
6.15%
FCF 3-Yr CAGR
-15.57%
Per Share Metrics
EPS (Diluted)
$-1.57
EPS (Basic)
$-1.57
Dividends / Share
N/A
Book Value / Share
$16.62
EPS YoY Growth
81.59%
Balance Sheet (FY 2025)
Total Assets
$13.80M
Total Liabilities
$91.30M
Stockholders' Equity
$778.20M
Current Assets
$13.80M
Current Liabilities
$91.30M